Cochrane · systematic review · CD009497
Electrocoagulation for liver metastases
Storman, D, Swierz, MJ, Riemsma, RP, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
Hepato-BiliaryAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
10
current version
GRADE rated
4
No studies
6
Included studies
NR
No studies 6 · 60%Ungraded 0 · 0%Very low 3 · 30%Low 1 · 10%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of Findings Table ‐ Electrocoagulation alone compared to control (vehicle solution of allopurinol by mouth) for people with liver metastases
Population: people with liver metastases
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality at last Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth) | RR 0.98 [0.94, 1.03] | 1 study · 113 participants | Very low Downgraded: risk of bias, imprecision |
Post‐operative deaths Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth) | RR 1.03 [0.07, 16.12] | 1 study · 152 participants | Very low Downgraded: risk of bias, imprecision |
Other adverse events and complications Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth) | no estimate extracted | NR | No studies |
Failure to clear liver metastases or recurrence of liver metastases Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth) | no estimate extracted | NR | No studies |
Tumour response Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth) | no estimate extracted | NR | No studies |
Summary of Findings Table ‐ Electrocoagulation in combination with allopurinol or with dimethyl sulphoxide compared to control (vehicle solution of allopurinol by mouth) for people with liver metastases
Population: people with liver metastases
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality at last Summary of Findings Table ‐ Electrocoagulation in combination with allopurinol or with dimethyl sulphoxide vs control (vehicle solution of allopurinol by mouth) | RR 0.87 [0.8, 0.95] | 1 study · 165 participants | Low Downgraded: risk of bias, imprecision |
Post‐operative deaths Summary of Findings Table ‐ Electrocoagulation in combination with allopurinol or with dimethyl sulphoxide vs control (vehicle solution of allopurinol by mouth) | RR 0.99 [0.09, 11.06] | 1 study · 231 participants | Very low Downgraded: risk of bias, imprecision |
Other adverse events and complications Summary of Findings Table ‐ Electrocoagulation in combination with allopurinol or with dimethyl sulphoxide vs control (vehicle solution of allopurinol by mouth) | no estimate extracted | NR | No studies |
Failure to clear liver metastases or recurrence of liver metastases Summary of Findings Table ‐ Electrocoagulation in combination with allopurinol or with dimethyl sulphoxide vs control (vehicle solution of allopurinol by mouth) | no estimate extracted | NR | No studies |
Tumour response Summary of Findings Table ‐ Electrocoagulation in combination with allopurinol or with dimethyl sulphoxide vs control (vehicle solution of allopurinol by mouth) | no estimate extracted | NR | No studies |